Tehran University of Medical Sciences
home | Farsi
Print

Davood Beiki

Contact Information
http://tums.ac.ir/faculties/beikidav
Tel: 88220361
Fax: 88026905
Address: Research Center for Nuclear Medicine, Shariati Hospital, North Kargar Ave., 14117-13135 Tehran, Iran
Academic Rank
Professor
School
Medicine
Nuclear medicine
Hospital
Shariati
Nuclear medicine
Research Center
Research Institute for Nuclear Medicine
About
Dr. Davood Beiki acquired a PharmD in 1995 from the Tehran University of Medical Sciences (TUMS) and then finished a PhD in Radiopharmacy in 1999 from TUMS. He gained a postdoctoral training in Radiochemistry/Radiopharmacy at the University of Alberta in 2000. Dr. Beiki has obtained the honor of full professorship of TUMS since 2012. He has been involved in Research Center for Nuclear Medicine of TUMS as a Co-Founder and Vice-Chair since 2006.
CV last edited on: 2017/11/06

1.

Postdoctoral fellowship


Radiochemistry/Radiopharmacy, University of Alberta, Edmonton, Canada, 1999- 2000
Thesis Title:1- Synthesis of 1-b-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (b-IAZA): a novel marker of tissue hypoxia., 2-Synthesis of b-azomycin nucleosides: 1-(b-D-2-iodo-2-deoxyarabinofuranosyl)-2-nitroimidazole, a novel marker of tissue hypoxia
Supervisor:Professor Leonard Wiebe
2.

Ph.D


Nuclear Pharmacy, Tehran University of Medical Sciences, Tehran, Iran, 1995-1999
Thesis Title:Tumor Imaging Agents: 1-Synthesis of tissue hypoxia Markers, 2- Radioiodination of antibodies
3.

Pharm D


Doctor of Pharmacy , Tehran University of Medical Sciences, Tehran, Iran, 1989-1995
Thesis Title:Comparative bioavailability of two tablet formulations of dipyridamole in healthy male volunteers
1.

English


2.

Persian - Farsi


1.

Razi Award for the foundations advocating medical sciences researches, Razi International Festival of Medical Sciences in Research, Tehran, Iran


2005,
2.

ARS Maurice H. Cottle Award, 51st Annual Meeting of the American Rhinologic Society, Los Angeles, California, USA


2005,
3.

Avicenna Award (Tehran University of Medical Sciences) for the young researcher, Tehran, Iran


2003,
4.

Razi Award for the young researcher in basic sciences, Razi International Festival of Medical Sciences in Research, Tehran, Iran


2003,

Scientific Position

1.

Professor of Nuclear Pharmacy


Research Institute for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, Since 2012
2.

Associate Professor of Nuclear Pharmacy


Research Institute for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2006-2011
3.

Assistant Professor of Nuclear Pharmacy


Research Institute for Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2000-2005

Executive Position

1.

Deputy for Research


Department of Nuclear Medicine, Faculty of Medicine, Tehran University of Medical Sciences, 2001-up to now
2.

Co-Founder and Deputy President


Research Institute for Nuclear Medicine, Tehran University of Medical Sciences, 2001-up to now
1.

Introduction to Research Ethics


Virtual School, TUMS, Iran, 8 March 2017, Learner
2.

OvidSP Platform


Wolters Kluwer, Tehran, Iran, 16 November 2015, Learner
3.

Plagiarism Workshop


Kowsar Academy, Tehran, Iran, 27 November 2014, Learner
4.

Clinical Research and Drug Safety


Merck Serono Company, The Middle East and Near East Region, 19 December 2013, Learner
5.

Workshop for Blood and Blood Component Handeling & Haemovigilance System


Iranian Blood Transfusion Organization, 31 October 2013, Learner
6.

Basic cGMP and Quality Control of 18F-FDG


Eczacibaci/Monrol Company, Turkey, 19-23 November 2012, Learner
7.

Requirements for Board Exam forTeachers


The Ministry of Health and Medical Education, Iran, 16 August 2012, Learner
8.

Workshop for Implementation of Relative Value of Health Services


The Ministry of Health and Medical Education, Iran, 1 February 2011, Learner
9.

Open Journal Systems (OJS) - Workshop


Tehran University of Medical Sciences, Tehran, Iran, 16 January 2011, Learner
10.

The Methods of Standard Setting


Tehran University of Medical Sciences, Tehran, Iran, June 2007, 13 Lecturer
11.

Knowledge Translation & Utilization of Research Results


Tehran University of Medical Sciences, Tehran, Iran, 13 December 2006, Learner
12.

SPSS Software


Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 30-31 May 2006, Learner
13.

Exam Evaluating and Questions Preparation


Tehran University of Medical Sciences, Tehran, Iran, 5 May 2006 , Learner
14.

Radiopharmaceuticals Quality Control


Atomic Energy Organization of Iran , Tehran, Iran, 11-15 March 2006, Learner
15.

EndNote Software


Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 22-23 December 2005, Learner
16.

Reference Manager Software


Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 18-20 September 2005, Learner
17.

Scientific writing


Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran, 23 February 2005, Learner
18.

Research Methodology


Institute of Public Health Researches, Tehran University of Medical Sciences, Tehran, Iran, 18-25 October, 2000, Learner
19.

Radiation Safety Course


Radiation Control Committee, University of Alberta, Canada, 3-8 February 2000, Learner
1.

Efficacy of adding bone-seeking radiopharmaceuticals (samarium-153 or strantium-89)on local radiation in metstatic bone involvement


Status: Completed, 2016
2.

Preparation, quality control and biodistribution study of radiolabelled Bombesin nanoparticles for In Vivo Gastrin Releasing Peptide-Receptor Imaging


Status: Running, 2015
3.

Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease and its differentiation from other types of parkinsonism syndroms


Status: Completed, 2015
4.

Synthesis, quality control and biodistribution study of 99mTc-labeled α-MSH derivative for diagnosis of melanoma


Status: Completed, 2014
5.

The relationship between nephropathy in diabetes mellitus type 2 and severity and extent of myocardial ischemia and myocardial dysfunction


Status: Completed, 2013
6.

Evaluation of the quality of life in patients with differentiated thyroid carcinoma treated with radioiodine-131 in Dr. Sahriati hospital


Status: Completed, 2012
7.

Evaluation of post-thyroidectomy preablative thyroglobulin and anti-thyroglobulin level relation with radioiodine therapy response in patients with differentiated thyroid cancer


Status: Completed, 2012
8.

Radiolabeling, quality control and biological evaluation of non-peptide CRCR4 antagonists for targeted diagnosis and therapy of malignancies


Status: Completed, 2012
9.

Comparison of radiosynovectomy efficacy with Re 188 sulfur colloid and Y-90 colloid in patient with chronic inflammatory knee joint disease


Status: Completed, 2011
10.

The evaluation of Re-HEDP efficacy in metastatic bone pain pallation therapy


Status: Completed, 2011
11.

Evaluation of 99mTc-bombesin in the diagnosis of breast cancer and its differentiation from benign lesions


Status: Completed, 2011
12.

Compensation for collimator-detector blurring for brain SPECT resolution enhancement


Status: Completed, 2010
13.

Salivary gland function evaluation after radioiodine therapy with doses equal or less than 100 mCi for either thyroid cancer or hyperthyroid state


Status: Completed, 2010
14.

Cardiac perfusion changes in patients treated for breast cancer with radiation therapy


Status: Completed, 2010
15.

Synthesis, quality control and biodistribution study of some 99mTc-labeled substance P derivatives for diagnosis of nerokinin receptor (NKr) expressing tumors


Status: Completed, 2010
16.

The image quality and myocardial to visceral uptake ratio in myocardial perfusion scan using pharmacological stress with sub-maximal exercise in comparison with pharmacological stress alone.


Status: Completed, 2009
17.

Evaluation of myocardial perfusion scintigraphy with Tc-99m sestamibi by ECG Gated SPECT method in determining one year prognosis of patients suspicious for coronary artery disease


Status: Completed, 2009
18.

Evaluation of abormal findings in myocardial perfusion scan of asymptomatic diabetic patients


Status: Completed, 2009
19.

Evaluation of Tc-99m Ubiquicidine in specific diagnosis of infection and differentiate it from noninfectional inflammations in diabetic patients foot ulcers


Status: Completed, 2009
20.

Evaluation of Tc-99m Ubiquicidine in specific diagnosis of infection and differentiate it from noninfectional inflammations in orthopaedic infection


Status: Completed, 2009
21.

Evaluation of different factors related to the patient or procedural techniques inducing reverse perfusion pattern in myocardial perfusion scan with Tc 99m MIBI


Status: Completed, 2009
22.

Evaluation of the efficacy and complications of 153Sm-EDTMP in palliative therapy of multiple bone metastases


Status: Completed, 2008
23.

Evaluation of short-term efficacy of I-131 re-treatment in patients with differentiated thyroid cancer who have undetectable stimulated serum Tg levels and positive whole body scan in thyroid bed after initial ablative therapy


Status: Completed, 2007
24.

The value of myocardial perfusion and function assessment with 99mTc-MIBI Gated SPECT before and after low dose dobutamine in prediction of the perfusion and function improvement after revascularization


Status: Completed, 2007
25.

Evaluation of the correlation between serum creatinin and GFR in acute renal necrosis in comparison with other causes of acute renal failure


Status: Completed, 2007
26.

Evaluation of nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma


Status: Completed, 2007
27.

Evaluation of the effect of low dose dobutamine infusion on 99mTc-MIBI redistribution in patients with coronary artery disease using SPECT gamma camera


Status: Completed, 2007
28.

Evaluation of protective effects of Hesperidin against genetic damage induced by 99mTechnetium-MIBI in human peripheral blood lymphocytes


Status: Completed, 2007
29.

Evaluation of effectiveness of Vit E and Bethanechol for prevention of salivary gland dysfunction in thyroid cancer patients candidated for radioiodine therapy


Status: Completed, 2006
30.

Agreement of two methods of planar and SPECT scintigraphy with Tc-99m RBC in detection of liver hemangioma


Status: Completed, 2006
31.

Evaluation of the effect of discontinuing beta-blocker drugs on dipyridamole myocardial perfusion imaging (DMPI) in patients who were on long-term beta-blocker therapy


Status: Completed, 2006
32.

Evaluation of diagnostic value of single injection-double acquisition gated SPECT imaging with low dose dobutamine-enhancement in comparison with conventional myocardial perfusion scan with 99m Tc-MIBI for diagnosis of myocardial perfusion abnormalities


Status: Completed, 2006
33.

Comparison of myocardial perfusion between chemical warefare victims and normal individuals by SPECT


Status: Completed, 2005
34.

The prevalence of increased gastric wall radiotracer uptake in Sestamibi myocardial perfusion SPECT and its association with symptoms of dyspepsia


Status: Completed, 2005
35.

Assessment of different filters for reconstruction of the images in myocardial SPECT based upon image contrast and diagnostic value of scan for diagnosis of coronary artery disease


Status: Completed, 2004
36.

ٍEvaluation of therapeutic efficacy of treatment with olanzapine and halopridol on regional cerebral blood flow messured by SPECT in patients with schizophrenia; correlating with the response to treatment


Status: Completed, 2004
37.

Efficacy of 99mTc-Phytate for pre and intraoperative sentinel lymph node detection in the breast cancer


Status: Completed, 2004
38.

Nuclear medicine cardiac SPECT and its denoising by Platelet-based Maximum Penalaized Likelihood Estimation (MPLE) method


Status: Completed, 2004
39.

Value of Tc99m-MIBI scintigraphy in the diagnosis of multiple drug resistance in multiple myeloma patients


Status: Completed, 2004
40.

Evaluation of diagnostic accuracy of myocardial perfusion scans with different patterns of interpretation in identification of coronary artery disease among patients with left bundle branch block


Status: Completed, 2004
41.

Evaluation of the diagnostic accuracy of sentinel node biopsy (SLN) in staging of breast cancer with Lymph node dissection under guiding of scintigraphic probe using 99mTc-Sb2S2


Status: Completed, 2004
42.

Bone SPECT value for differentiating malignant from benign lesions of vertebral column in patients with known primary malignancy


Status: Completed, 2004
43.

Evaluation of relative occurrence of mother and fetus complications in women with differentiated thyroid carcinoma treated with radioactive iodine


Status: Completed, 2004
44.

Myocardial perfusion scan role in evaluating Percutaneous Transluminal Coronary Angioplasty (PTCA) in patients with coronary artery disease


Status: Completed, 2004
45.

Preparation of patients with thyroid cancer for I131 scintigraphy or therapy by 1-3 weeks of levothyroxine discontinuation or after total thyroidectomy


Status: Completed, 2003
46.

Study of treatment of thyroid carcinoma using low 131I<1110MBq in comparison with that of routinly used high activity 131-I>3660MBq


Status: Completed, 2003
47.

A Comparative study between Tc-EC 99m and 99m-TcMAG3 in evaluation of renal function in patients


Status: Completed, 2003
48.

Evaluation of dacryoscintigraphy in the diagnosis of lacrimal apparatus obstruction


Status: Completed, 2003
49.

Evaluation of the diagnostic value of erythrocyte sedimentation rate (ESR) and absolute neutrophil count in detection of pyelonephritis (based on the DMSA scan findings) in children with first time urinary tract infections


Status: Completed, 2003
50.

Assessment of treatment requirement in patient with differentiated thyroid cancer and undetectable serum thyroglobulin and positive 131-I whole body scan only in thyroid bed


Status: Completed, 2003

Advisor/Consulter

1.

Assessment of relationship between tumor markers level and FDG-PET/CT scan findings in colorectal carcinoma patients


Ali Kafshgar,
MD, Nuclear Medicine Specialty, 2017
2.

Assessment of correlation between gastric FDG uptake and 14C-UBT results


Fatemeh Farsyabi,
MD, Nuclear Medicine Specialty, 2017
3.

Assessment of relationship between thyroglobulin and thyroglobulin antibody levels and FDG-PET/CT scan findings in differentiated thyroid cancer patients


Hila Aghaei,
MD, Nuclear Medicine Specialty, 2017
4.

Assessment of lower limbs perfusion with 99mTc-MIBI in patients with intermediate pretest probability of coronary artery disease referred for myocardial perfusion imaging


Sanaz Katal,
MD, Nuclear Medicine Specialty, 2016
5.

Efficacy of adding bone-seeking radiopharmaceuticals (samarium-153 or strantium-89)on local radiation in metastatic bone involvement


Saeed Davoodian,
MD, Radiation Oncology Specialty, 2016
6.

Evaluation of delayed cardiac perfusion changes in patients with breast cancer treated by radiotherapy


Forough Kalantari,
MD, Nuclear Medicine Specialty, 2016
7.

Comparison of sensitivity and specificity of Tc-99m somatostatin analogs (octreotide) and I-131 MIBG scintigraphies in diagnosis and localization of pheochromocytoma and neuroblastoma


Arefeh Mirzabeigi,
MD, Nuclear Medicine Specialty, 2016
8.

Evaluation of correlative factors and patterns of FDG myocardial uptake in the patient's with malignancy


Bahar Mossess Ghafari,
MD, Nuclear Medicine Specialty, 2016
9.

Synthesis, radiolabeling, quality control and biological evaluation of LIKKPF peptide and its analogs with 18F-FDG for in vivo imaging of apoptosis


Sepideh Khoshbakht,
Ph.D, Radiopharmacy, 2016
10.

Evaluation of post-thyroidectomy preablative thyroglobulin and anti-thyroglobulin level relation with radioiodine therapy response in patients with differentiated thyroid cancer


Mohammad Reza Valipouri,
MD, Nuclear Medicine Specialty, 2015
11.

Novel combined agents for palliative treatment of bone pain


Hasan Ranjbar,
Ph.D, Physics- Medical Radiation, 2015
12.

Synthesis, quality control and biodistribution study of 99mTc-labeled α-MSH derivative for diagnosis of melanoma


Danial Shamshirian,
Ph.D, Radiopharmacy, 2015
13.

Assessment of post stress stunning in diagnosis and classification of patients with suspected CAD


Asghar Akbari,
MD, Nuclear Medicine Specialty, 2015
14.

Assessment of prognosis and prognostic factors in patients with lymph node involvement from differentiated thyroid carcinoma origin


Mehraneh Mostafavi,
MD, Nuclear Medicine Specialty, 2015
15.

Comparative evaluation of prognosis in patients with differentiated thyroid cancer based on elevated tg (>2ng/dl) and whole body scan findings after ablative therapy


Negar Ahmadpour,
MD, Nuclear Medicine Specialty, 2015
16.

Evaluation of prognosis and factors effective of pediatric patients(<18yr)with differentiated thyroid carcinoma


Masoomeh Havasi,
MD, Nuclear Medicine Specialty, 2015
17.

Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease and its differentiation from other types of parkinsonism syndroms


Atefeh Esmaeili,
MD, Nuclear Medicine Specialty, 2015
18.

Regulations and policies concerning the manufacture, preparation, importation, exportation, transportation and waste management of radiopharmaceuticals


Hesam Alibakhshi,
M.Sc, Pharmaceutical regulatory affairs/quality assurance, 2015
19.

Radiolabeling, quality control and biological evaluation of the AMD3100 as non-peptide CXCR4 antagonist for targeted diagnosis of related human malignancies and optimization of its synthesis


Ayuob Aghanejad,
Ph.D, Radiopharmacy, 2015
20.

Preparation and quality control of radio-labeled Porphyrin derivatives with radiolanthanides for therapeutic purposes


Nasim Vahidfar,
Ph.D, Radiopharmacy, 2014
21.

Evaluation of relationship between nephropathy and severity/extent of cardiac ischemia in type 2 diabetic patients by myocardial perfusion scan


Niloofar Tavakoli,
MD, Nuclear Medicine Speciality, 2014
22.

Evaluation of short-term efficacy of I-131 re-treatment in patients with differentiated thyroid cancer who have undetectable stimulated serum Tg levels and positive whole body scan in thyroid bed after initial ablative therapy


Somayeh Sahari,
MD, Nuclear Medicine Speciality, 2014
23.

Assessment of related factors in patients with CAD and mild to sever LV dysfunction by phase analysis of gated-SPECT myocardial perfusion imaging


Afsaneh Khorami,
MD, Nuclear Medicine Speciality, 2014
24.

Radiolabeling, quality control and biological evaluation of the AMD3100 as non-peptide CXCR4 antagonist for targeted diagnosis of related human malignancies and optimization of its synthesis


Ayoub Aghanezhad,
Ph.D, Radiopharmacy, 2014
25.

Production of a new peptide analog of neurotensin and lebeling it with 99mTc for detection of NT1 positive receptors


Nakisa Zarrabi,
Ph.D, Cell and Molecular Biology, 2013
26.

In vitro screening of new Triazol and Oxadiazole derivatives as benzodiazepine receptor agonists, using radioligand receptor binding assays


Fatemeh Ahmadi,
Ph.D, Radiopharmacy, 2013
27.

Evaluation of the sensitivity and normalcy rate of myocardial perfusion scan using SPECT vs. SPECT-CT for the diagnosis of ischemic heart disease


Arman Hasanzadeh,
MD, Nuclear Medicine Speciality, 2013
28.

The evaluation of Re-HEDP efficacy in metastatic bone pain pallation therapy


Maryam Tajik,
MD, Nuclear Medicine Speciality, 2012
29.

Cardiac perfusion changes in patients treated for breast cancer with radiation therapy


Hanieh Zamani,
MD, Nuclear Medicine Speciality, 2012
30.

Evaluation of the quality of life in patients with differentiated thyroid carcinoma treated with radioiodine-131


Seyed Kazem Razavi,
MD, Nuclear Medicine Speciality, 2012
31.

Synthesis, quality control and biodistribution study of some 99mTc-labeled substance P derivatives for diagnosis of nerokinin receptor (NKr) expressing tumors


Saeed Mozafari,
Ph.D, Radiopharmacy, 2012
32.

Evaluation of different factors related to the patient or procedural techniques inducing reverse perfusion pattern in myocardial perfusion scan with Tc 99m MIBI


Yalda salehi,
MD, Nuclear Medicine Speciality, 2011
33.

Protective effects of hesperidin against genotoxicity induced by 99mTc-MIBI in human cultured lymphocyte cells


Amirhossein Ahmadi,
Pharm D, Pharmacy, 2010
34.

Evaluation of the effect of concurrent submaximal exercise and pharmacologic stress on subdiaphragmatic activities in myocardial perfusion scan


Farahnaz Aghahosseini,
MD, Nuclear Medicine Speciality, 2010
35.

Salivary gland function evaluation after radioiodine therapy with doses equal or less than 100 mCi for either thyroid cancer or hyperthyroid state


Mohammad Karimi,
MD, Nuclear Medicine Speciality, 2010
36.

Evaluation of the effect of low dose dobutamine infusion on 99mTc-MIBI redistribution in patients with coronary artery disease using SPECT gamma camera


Zhila Mohseni,
Ph.D, Radiopharmacy, 2010
37.

Comparing the diagnostic sensitivity and specificity of cardiac perfusion imaging with 99mTc-MIBI in five defined protocols


Mahdi Haghighatafshar,
MD, Nuclear Medicine Speciality, 2010
38.

99mTc-Ubiquicidin [29–41], a Promising Radiopharmaceutical to Differentiate Orthopedic Implant Infections from Sterile Inflammation


Gholamali Yousefi,
MD, Nuclear Medicine Speciality, 2009
39.

Evaluation of 99mTc-Ubiquicidin 29–41 Scintigraphy in Differentiation of Bacterial Infection from Sterile Inflammation in Diabetic Foot


Mohammadreza Gharaei,
MD, Nuclear Medicine Speciality, 2009
40.

Evaluation of the efficacy and complications of 153Sm-EDTMP in palliative therapy of multiple bone metastases


Arash Keivan,
MD, Nuclear Medicine Speciality, 2009
41.

Evaluation of effectiveness of Vit E and Bethanechol for prevention of salivary gland dysfunction in thyroid cancer patients candidated for radioiodine therapy


Seyed Mohammad Abedi,
MD, Nuclear Medicine Speciality, 2008
42.

Evaluation of the correlation between serum creatinin and GFR in acute renal necrosis in comparison with other causes of acute renal failure


Alireza Emami-Ardekani,
MD, Nuclear Medicine Speciality, 2008
43.

Evaluation of nasolacrimal duct obstruction associated with radioactive iodine therapy for thyroid carcinoma


Saeed Farzanefar,
MD, Nuclear Medicine Speciality, 2008
44.

The value of myocardial perfusion and function assessment with 99mTc-MIBI Gated SPECT before and after low dose dobutamine in prediction of the perfusion and function improvement after revascularization


Morteza Bostani,
MD, Nuclear Medicine Speciality, 2008
45.

Evaluation of the clinical and laboratory findings in predicting of acute renal lesions by 99mTc-DMSA scan in children with first urinary tract infection


Amir Gholami,
MD, Nuclear Medicine Speciality, 2007
46.

Evaluation of scintigraphic patterns of bone metastases in patients with different types of cancers


MohammadBagher Khodaparast,
MD, Medical Doctor, 2007
47.

Evaluation of dacroscintigraphy in the diagnosis of lacrimal apparatus obstruction


Ali Gholamrezanezhad,
MD, Nuclear Medicine Speciality, 2006
48.

Evaluation of I-131 treatment in patients with differentiated thyroid cancer who have high levels of serum Anti-Tg and normal whole body scan


Mozhgan NazarAhari,
MD, Nuclear Medicine Speciality, 2006
49.

Evaluation of patients with differentiated thyroid cancer with elevated Anti-Tg level and its correlation with serum TG level and whole body scan with I-131


Sahar Mirpour,
MD, Nuclear Medicine Speciality, 2006
50.

Evaluation of adioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma


Mahsa Hadifar,
MD, Medical Doctor, 2006
51.

The value of sentinel lymph node biopsy detected by lymphoscintigraphy with 99mTc-phytate and Blue dye technique in predicting pathological status of axillary lymph nodes in patients with breast cancer


Mohsen Arabi,
MD, Nuclear Medicine Speciality, 2005
52.

The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma


Hossein Mirshekarpour,
MD, Nuclear Medicine Speciality, 2004
53.

Determination of the best time for sample collection during the 14C-urea breath test for the diagnosis of helicobacter pylori infection


Mohammad Hossein Al-Seyed Hossein,
Pharm D, Pharmacy, 2003

Farsi

1.

Beiki D, Quality Control of Radiopharmaceuticals. In: Textbook of Nuclear Pharmacy. 2007; 195-235


Authors: Beiki D,
2007, Original

Papers

English

1.

Optimized production, quality control, biological evaluation and PET/CT imaging of 68Ga-PSMA-617 in breast adenocarcinoma model


Authors: Sharifi M, Yousefnia H, Bahrami-Samani A, Jalilian AR, Zolghadri S, Alirezapour B, Geramifar P, Maus S, Beiki D,
Radiochimica Acta, Vol.105, No.5, Year. 2017, Page:399-408,
2.

β-[18F]Fluoro Azomycin Arabinoside (β-[18F]FAZA): Synthesis, radiofluorination and preliminary PET imaging of murine A431 tumors


Authors: Kumar P, Roselt P, Reischl G, Cullinane C, Beiki D, Ehrlichmann W, Binns D, Naimi E, Yang J, Hicks R, Machulla HJ, Wiebe LI,
Curr Radiopharm, Year. 2017, Page:doi: 10.2174/1874471010666170313,
Download
3.

Radiation induced myocardial perfusion abnormalities in patients with left breast cancer: A prospective study with short and long term follow up


Authors: Eftekhari M, Kalantari F, Emami-Ardekani A, Amini H, Fard-Esfahani A, Fallahi B, Beiki D, Farzanefar S, Kalantari E, Hasanzadeh-Rad A, Abbasi M,
Iran J Nucl Med, Vol.25, No.Suppl 1, Year. 2017, Page:21-25,
Download
4.

Factors influencing the pattern and intensity of myocardial 18F-FDG uptake in oncologic PET-CT imaging


Authors: Fallahi B, Moasses-Ghafari B, Fard-Esfahani A, Geramifar P, Beiki D, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med, Vol.25, No.Suppl 1, Year. 2017, Page:52-61,
Download
5.

Chelator-free radiolabeling of dextran with 68Ga for PET studies


Authors: Gholipour N, Akhlaghi M, Mokhtari Kheirabadi A, Beiki D, Geramifar P, Yousefnia H, Mazidi M,
J Radioanal Nucl Chem, Year. 2017, Page:doi: 10.1007/s10967-016-5164-z,
Download
6.

Sentinel lymph node biopsy correctly predicts regional lymph node recurrence in trunk malignant melanoma with multiple drainage basins


Authors: Farzanefar S, Abbasi M, Beiki D,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:77-80,
Download
7.

Reverse perfusion pattern in myocardial perfusion imaging using technetium-99m-sestamibi in patients with intermediate risk for coronary artery disease in relation to the time of acquisition and intensity of visceral uptake as artifactual causes


Authors: Fallahi B, Beiki D, Salehi Y, Emami-Ardekani A, Fard-Esfahani A, Aghahosseini F, Haghighatafshar M, Eftekhari M,
Nucl Med Commun, Vol.38, No.1, Year. 2017, Page:15-20,
Download
8.

How to manage patients with undetectable thyroglobulin but thyroid residue after radioiodine ablative therapy in differentiated thyroid carcinoma, retreatment or observation


Authors: Fallahi B, Fard-Esfahani A, Emami-Ardekani A, Sahari S, Beiki D, Hassanzadeh-Rad A, Abedi SM, Geramifar P, Eftekhari M,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:51-59,
Download
9.

Development of 153Sm/177Lu-EDTMP as a possible therapeutic complex


Authors: Ranjbar H, Bahrami-Samani A, Beiki D, Ghannadi-Maragheh M,
Iran J Nucl Med, Vol.25, No.1, Year. 2017, Page:11-16,
Download
10.

Preparation and biodistribution assessment of 68Ga-DKFZ-PSMA-617 for PET prostate cancer imaging


Authors: Sharifi M, Yousefnia H, Zolghadri S, Bahrami-Samani A, Naderi M, Jalilian AR, Geramifar P, Beiki D,
Nucl Sci Tech, Vol.27, No.6:142, Year. 2016,
Download
11.

A 99mTc-tricine-HYNIC-labeled peptide targeting the melanocortin-1 receptor for melanoma imaging


Authors: Shamshirian D, Erfani M, Beiki D, Hajiramazanali M, Fallahi B,
Iran J Pharm Res, Vol.15, No.3, Year. 2016, Page:349-360,
Download
12.

18FDG-labeled LIKKPF: a PET tracer for apoptosis imaging


Authors: Khoshbakht S, Beiki D, Geramifar P, Kobarfard F, Sabzevari O, Amini M, Shahhosseini S,
J Radioanal Nucl Chem, Vol.310, Year. 2016, Page:413-421,
Download
13.

The present status of radiopharmaceuticals in the country


Authors: Jalilian AR, Beiki D,
Iran J Pharm Res, Vol.15, No.3, Year. 2016, Page:257-259,
Download
14.

Spinal cord metastasis from testicular seminoma detected by F-18 FDG PET/CT study prior to neurological symptoms: An unusual presentation


Authors: Fard-Esfahani A, Marzban M, Emami-Ardekani A, Hassanzadeh-Rad A, Fallahi B, Beiki D, Geramifar P, Eftekhari M,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:146-148,
Download
15.

Production of 68Ga-citrate based on a SnO2 generator for short-term turpentine oil-induced inflammation imaging in rats


Authors: Mirzaei A, Jalilian AR, Akhlaghi M, Beiki D,
Curr Radiopharm, Year. 2016, Page: [Epub ahead of print],
Download
16.

Two-day stress-rest lower limbs perfusion scan in patients referred for myocardial perfusion imaging


Authors: Katal S, Hassanzadeh-Rad A, Eftekhari M, Fard-Esfahani A, Beiki D, Fallahi B, Emami-Ardekani A, Abbasi M,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:120-128,
Download
17.

Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran


Authors: Jalilian AR, Beiki D, Hassanzadeh-Rad A, Eftekhari A, Geramifar P, Eftekhari M,
Semin Nucl Med, Vol.46, No.4, Year. 2016, Page:340-358,
Download
18.

Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease versus other progressive movement disorders


Authors: Fallahi B, Esmaeili A, Beiki D, Oveisgharan S, Noorollahi-Moghaddam H, Erfani M, Tafakhori A, Rohani M, Fard-Esfahani A, Emami-Ardekani A, Geramifar P, Eftekhari M,
Ann Nucl Med, Vol.30, No.2, Year. 2016, Page:153-62,
Download
19.

Factors affecting the quality of life of well-differentiated thyroid carcinoma patients: A cross-sectional study on 435 Iranian patients


Authors: Razavi Ratki SK, Fallahi B, Namiranian N, Emami-Ardekani A, Saghari M, Mirabzadeh A, Fard-Esfahani A, Beiki D, Eftekhari M, Pooyafard F,
Iran J Nucl Med, Vol.24, No.2, Year. 2016, Page:92-97,
Download
20.

Synthesis, radiolabeling, and biological evaluation of peptide LIKKPF functionalized with HYNIC as apoptosis imaging agent


Authors: Khoshbakht S, Beiki D, Geramifar P, Kobarfard F, Sabzevari O, Amini M, Mehrnejad F, Shahhosseini S,
Iran J Pharm Res, Vol.15, No.2, Year. 2016, Page:415-424,
Download
21.

Development of 68Ga Ethyl Cysteinate Dimer for PET studies


Authors: Mirzaei A, Jalilian AR, Shabani G, Mazidi M, Akhlaghi M, Beiki D,
J Radioanal Nucl Chem, Vol.307, Year. 2016, Page:725-732,
Download
22.

Optimized production and quality control of 68Ga-DOTATATE


Authors: Aghanejad A, Jalilian AR, Maus S, Yousefnia H, Geramifar P, Beiki D,
Iran J Nucl Med, Vol.24, No.1, Year. 2016, Page:29-36,
Download
23.

HYNIC a bifunctional prosthetic group for the labelling of peptides with 99m Tc and 18 FDG


Authors: Khoshbakht S, Kobarfard F, Beiki D, Sabzevari O, Amini M, Mehrnejad F, Tabib K, Shahhosseini S,
J Radioanal Nucl Chem, Vol.307, Year. 2016, Page:1125-34,
Download
24.

Preparation and Quality Control of 111In-Plerixafor for Chemokine Receptor CXCR4


Authors: Aghanejad A, Jalilian AR, Bolourinovin F, Mirzaee A, Abdi K, Erfani M, Beiki D, Maus S, Khalaj A,
Recent Patents and Topics on Imaging, Vol.5, No.1, Year. 2015, Page:26-30,
Download
25.

Folate therapy improves the stress-to-rest mean LV volume ratio in myocardial perfusion imaging in patients with diabetes


Authors: Emami-Ardekani A, Esteghamati A, Farzanefar S, Abousaidi M, Abbasi M, Abdollahi S, Fallahi B, Beiki D, Fard-Esfahani A, Nakhjavani M, Eftekhari M,
Ann Nucl Med, Vol.29, No.8, Year. 2015, Page:740-4,
Download
26.

Development of a 99mTc-labeled lactam bridge-cyclized alpha- MSH derivative peptide as a possible single photon imaging agent for melanoma tumors


Authors: Shamshirian D, Erfani M, Beiki D, Fallahi B, Shafiei M,
Ann Nucl Med, Vol.29, Year. 2015, Page:709-20,
Download
27.

Preparation and evaluation of 68Ga-ECC as a PET renal imaging agent


Authors: Mirzaei A, Jalilian AR, Aghanejad A, Mazidi M, Yousefnia H, Shabani G, Ardaneh K, Geramifar P, Beiki D,
Nucl Med Mol Imaging, Vol.49, Year. 2015, Page:208-216,
Download
28.

Preparation of a 153Sm-5,10,15,20-tetrakis(4-methoxyphenyl) porphyrin complex as a possible therapeutic agent


Authors: Vahidfar S, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, Khalaj A,
Iran J Nucl Med, Vol.23, No.2, Year. 2015, Page:65-72,
Download
29.

Optimized production and quality control of 68Ga-EDTMP for small clinical trials


Authors: Mirzaei A, Jalilian AR, Badbarin A, Mazidi M, Morshojaei F, Geramifar P, Beiki D,
Ann Nucl Med, Vol.29, No.6, Year. 2015, Page:506-511,
Download
30.

Evaluation of a new 99mTc-Bombesin analog in differentiation of malignant from benign breast tumors


Authors: Beiki D, Karami F, Fallahi B, Kaviani A, Harirchi I, Omranipour R, Erfani M, f Farzanefar S, Fard-Esfahani A, Emami-Ardekani A, Saghari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.2, Year. 2015, Page:103-107,
Download
31.

Assessment of prognostic value of semiquantitative parameters on gated single photon emission computed tomography myocardial perfusion scintigraphy in a large middle eastern population


Authors: Chavoshi M, Fard-Esfahani A, Fallahi B, Emami-Ardekani A, Beiki D, Hassanzadeh-Rad A, Eftekhari M,
Indian J Nucl Med, Vol.30, No.3, Year. 2015, Page:233-238,
Download
32.

Dosimetric evaluation of 153Sm-EDTMP, 177Lu-EDTMP and 166Ho-EDTMP for systemic radiation therapy: Influence of type and energy of radiation and half life of radionuclides


Authors: Ranjbar S, Ghannadi-Maragheh M, Bahrami-Samani A, Beiki D,
Radiat Phys Chem, Vol.108, Year. 2015, Page:60-64,
Download
33.

Effectiveness and complications of 188Re-HEDP in palliative treatment of diffuse skeletal metastases


Authors: Beiki D, Tajik M, Haddad P, Fallahi B, Arefpour AM, Mirzaei H, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:44-48,
Download
34.

Radiation-induced myocardial perfusion abnormalities in breast cancer patients following external beam radiation therapy


Authors: Eftekhari M, Anbiaei R, Zamani H, Fallahi B, Beiki D, Ameri A, Emami-Ardekani A, Fard-Esfahani A, Gholamrezanezhad A, Razavi Ratki SK, Momen Roknabadi A,
Asia Oceania J Nucl Med Biol, Vol.3, No.1, Year. 2015, Page:3-9,
Download
35.

Preparation and preliminary biological evaluation of [153Sm] samarium AMD3100; towards a possible therapeutic chemokine receptor CXCR4 targeting complex


Authors: Aghanejad A, Jalilian AR, Bahrami-Samani A, Beiki D, Maus S, khalaj A,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:36-43,
Download
36.

Synthesis and preliminary evaluation of a new 99mTc labeled substance P analogue as a potential tumor imaging agent


Authors: Mozafari S, Erfani M, Beiki D, Johari Daha F, Kobarfard F, Balalaie S, Fallahi B,
Iran J Pharm Res, Vol.14, No.1, Year. 2015, Page:97-110,
Download
37.

Evaluation of 153Sm/177Lu-EDTMP mixture in wild-type rodents as a novel combined palliative treatment of bone pain agent


Authors: Ranjbar S, Bahrami-Samani A, Beiki D, Shirvani-Arani S, Ghannadi-Maragheh M,
J Radioanal Nucl Chem, Vol.303, No.1, Year. 2015, Page:71-79,
Download
38.

The myocardial perfusion scintigraphy in asymptomatic diabetic patients


Authors: Salehi Y, Fard-Esfahani A, Fallahi B, Aghahosseini F, Beiki D, Emami-Ardekani A, Fard-Esfahani P, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:27-35,
Download
39.

Changes in salivary gland function following radioiodine therapy of thyroid diseases: A comparison of high-dose therapy for thyroid cancer and low-dose therapy for benign thyroid disease


Authors: Fard-Esfahani A, Fallahi B, Karimi M, Beiki D, Saghari M, Emami-Ardekani A, Fard-Esfahani P, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.23, No.1, Year. 2015, Page:1-7,
Download
40.

The potential role of pretransplant MIBG diagnostic scintigraphy in targeted administration of 131 I-MIBG accompanied by ASCT for high-risk and relapsed neuroblastoma: A pilot study


Authors: Hamidieh AA, Beiki D, Paragomi P, Fallahi B, Behfar M, Fard-Esfahani A, Hosseini AS, Shamshiri A, Eftekhari M, Ghavamzadeh A,
Pediatr Transplant, Vol.18, No.5, Year. 2014, Page:510-517,
Download
41.

Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma


Authors: Fard-Esfahani A, Emami-Ardekani A, Fallahi B, Fard-Esfahani P, Beiki D, Hassanzadeh-Rad A, Eftekhari M,
Nucl Med Commun, Vol.35, No.8, Year. 2014, Page:808-817,
Download
42.

Development of radiolanthanide labeled porphyrin complexes as possible therapeutic agents in beast carcinoma xenografts


Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Aghanejad A, Bahrami-Samani A, Alirezapoor B, Erfani M, Beiki D, Khalaj A,
Radiochimica Acta, Vol.102, No.7, Year. 2014, Page:659-668,
Download
43.

Comparison of transient ischemic dilation ratios in SPECT and SPECT-CT myocardial perfusion imaging in the low pre-test probability group


Authors: Fallahi B, Fard-Esfahani A, Hassanzadeh-Rad A, Emami-Ardekani A, Beiki D, Eftekhari M,
Iran J Nucl Med, Vol.22, No.2, Year. 2014, Page:51-56,
Download
44.

Radiosynthesis and biological evaluation of 166Ho labeled methoxylated porphyrins as possible therapeutic agents


Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, khalaj A,
J Radioanal Nucl Chem, Vol.301, No.1, Year. 2014, Page:269-276,
Download
45.

Preparation and evaluation of a new neurotensin analog labeled with 99mTc for targeted imaging of neurotensin receptor positive tumors


Authors: Zarrabi Ahrabi N, Erfani M, Parivar K, Beiki D, Jalilian AR,
J Radioanal Nucl Chem, Vol.299, Year. 2014, Page:461-469,
Download
46.

Accuracy of modification of diet for renal disease and Cockcroft-Gault equations as compared to the radioisotope double sample method: A study in patients with acute renal failure


Authors: Emami-Ardekani A, Fallahi B, Amini M, Fard-Esfahani A, Beiki D, Farzanefar S, Abbasi M, Sadeghian L, Eftekhari M, Saghari M,
Iran J Nucl Med, Vol.22, No.1, Year. 2014, Page:23-28,
Download
47.

Optimum conditions of radioligand receptor binding assay of ligands of benzodiazepine receptors


Authors: Ahmadi F, Dabirian S, Faizi M, Tabatabai SA, Beiki D, Shahhosseini,
Iran J Pharm Res, Vol.13, Year. 2014, Page:79-86,
Download
48.

Synthesis and Evaluation of [67Ga]-AMD3100; a novel imaging agent for targeting chemokine receptor CXCR4


Authors: Aghanejad A, Jalilian AR, Fazaeli Y, Alirezapoor B, Pouladi M, Beiki D, Maus S, Khalaj A,
Scientia Pharmaceutica, Vol.82, Year. 2014, Page:29-42,
Download
49.

Radiosynthesis and biodistribution studies of [62Zn/62Cu]-Plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging


Authors: Aghanejad A, Jalilian AR, Fazaeli Y, Beiki D, Fateh B, khalaj A,
J Radioanal Nucl Chem, Vol.299, Year. 2014, Page:1635-1644,
Download
50.

Comparison [3H]-flumazenil binding parameters in rat cortical membrane using different separation methods, filtration and centrifugation


Authors: Ahmadi F, Faizi M, Tabatabai SM, Beiki D, Shahhosseini S,
Nucl Med Biol, Vol.40, No.7, Year. 2013, Page:896-900,
Download
51.

Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer


Authors: Fallahi B, Beiki D, Abedi SM, Saghari M, Fard-Esfahani A, Akhzari F, Mokarami B, Eftekhari M,
Nucl Med Commun, Vol.34, No.8, Year. 2013, Page:777-786,
Download
52.

99mTc-Ubiquicidin [29–41], a promising radiopharmaceutical to differentiate orthopedic implant infections from sterile inflammation


Authors: Beiki D, Yousefi G, Fallahi B, Tahmasebi MN, Gholamrezanezhad A, Fard-Esfahani A, Erfani M, Eftekhari M,
Iran J Pharm Res, Vol.12, No.2, Year. 2013, Page:347-353,
Download
53.

Effectiveness and complications of 153Sm-EDTMP in palliative treatment of diffuse skeletal metastases


Authors: Beiki D, Haddad P, Fallahi B, Keyvan A, Gholamrezanezhad A, Mirzaei H, Saghari M, Amouzegar-Hashemi F, Kazemian A, Fard-Esfahani A, Eftekhari M,
Iran J Nucl Med, Vol.21, No.1, Year. 2013, Page:26-32,
Download
54.

Withholding or continuing beta-blocker treatment before dipyridamole myocardial perfusion imaging for the diagnosis of coronary artery disease? a randomized clinical trial


Authors: Fallahi B, Beiki D, Akbarpour S, Gholamrezanezhad A, Fard-Esfahani A, Akhzari F, Izadyar S, Esmaeli J, Saghari M, Eftekhari M,
DARU Journal of Pharmaceutical Sciences, Vol.21, No.1, Year. 2013,
Download
55.

Development and evaluation of a 166holmium labelled porphyrin complex as a possible therapeutic agent


Authors: Vahidfar N, Jalilian AR, Fazaeli Y, Bahrami-Samani A, Beiki D, khalaj A,
J Radioanal Nucl Chem , Vol.295, Year. 2013, Page:979-986,
Download
56.

Evaluation of myocardial perfusion and function after kidney transplantation by Gated SPECT myocardial perfusion scintigraphy


Authors: Fard-Esfahani A, Fallahi B, Mirpour S, Gholamrezanezhad A, Abdi E, Karimi M, Beiki D, Emami-Ardekani A, Akhzari F, Ansari M, Eftekhari M,
Iran J Nucl Med, Vol.20, No.2, Year. 2012, Page:20-24,
Download
57.

Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer


Authors: Fard-Esfahani A, Farzanefar S, Fallahi B, Beiki D, Saghari M, Emami-Ardekani A, Majdi M, Eftekhari M,
Nucl Med Commun , Vol.33, No.10, Year. 2012, Page:1077-80,
Download
58.

The influence of resolusion recovery by using collimator detector response during 3D OSEM image reconstruction on 99mTc-ECD brain SPET images


Authors: Kalantari F, Rajabi H, Ay MR, Razavi-Ratki SK, Fard-Esfahani A, Beiki D, Eftekhari M, Fallahi B, Sadeghian L, Emami-Ardekani A,
Hell J Nucl Med , Vol.15, No.2, Year. 2012, Page:92-97,
Download
59.

Low versus high radioiodine dose in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid carcinoma: a large randomized clinical trial


Authors: Fallahi B, Beiki D, Takavar A, Fard-Esfahani A, Ansari Gilani K, Saghari M, Eftekhari M,
Nucl Med Commun , Vol.33, No.3, Year. 2012, Number of Page:275-282
Download
60.

Renal axis deviation in urinary tract abnormalities of children: the role of renal scintigraphy


Authors: Ansari-Gilani K, Gholamrezanezhad A, Beiki D, Mirpour S, Modaresi Esfeh J,
Clin Nucl Med, Vol.36, No.12, Year. 2011, Page:1086-91,
Download
61.

Additive clinical value of bone scintigraphy in patients with malignant tumors with absence of localized bone pain: A report on most common sex-related cancers


Authors: Fallahi B, Beiki D, Khodaparast MB, Gholamrezanezhad A, Fard-Esfahani A, Eftekhari M,
Iran J Nucl Med , Vol.19, No.1, Year. 2011, Page:52-58,
Download
62.

Prospective evaluation of technetium-99m ECD SPET in mild traumatic brain injury for the prediction of sustained neuropsychological sequels


Authors: Mehrazin M, Nezameddini-Kachooei SA, Fallahi B, Derakhshan MK, Beiki D, Ghodsi SM, Assadi M, Pooyafard F, Eftekhari M,
Hell J Nucl Med , Vol.14, No.3, Year. 2011, Page:243-250,
Download
63.

Bone scan with incidental visualization of the entire colon


Authors: Eftekhari M, Fard-Esfahani A, Haghighatafshar M, Keyvan A, Beiki D, Aghahosseini F, Emami-Ardekani A, Saghari M,
Iran J Nucl Med , Vol.18, No.2, Year. 2010, Page:56-59,
Download
64.

Evaluation of 99mTc-Ubiquicidin 29–41 scintigraphy in differentiation of bacterial infection from sterile inflammation in diabetic foot


Authors: Fard-Esfahani A, Beiki D, Fallahi B, Mohajeri-Tehrani MR, Gharaie MR, Rouhipour N, Dehghanian M, Saghari M, Emami-Ardekani A, Eftekhari M,
Iran J Nucl Med , Vol.18, No.2, Year. 2010, Page:20-28,
Download
66.

McCune-Albright syndrome: Report of a case


Authors: Haghighatafshar M, Fard-Esfahani A, Karami F, Saghari M, Fallahi B, Beiki D, Aghahosseini F, Eftekhari M,
Iran J Nucl Med , Vol.18, No.1, Year. 2010, Page:57-61,
Download
67.

Successful application of technetium-99m-labeled octreotide acetate scintigraphy in the detection of ectopic adrenocorticotropin-producing bronchial carcinoid lung tumor: a case report


Authors: Esfahani AF, Chavoshi M, Noorani MH, Saghari M, Eftekhari M, Beiki D, Beiki D, Fallahi B, Assadi M,
J Med Case Reports , Vol.4, Year. 2010, Page:323,
Download
68.

The value of myocardial perfusion imaging with Tc-99m MIBI for the prediction of perfusion improvement after percutaneous transluminal coronary angioplasty


Authors: Fard-Esfahani A, Fallahi B, Mohagheghi A, Assadi M, Beiki D, Eftekhari M, Saghari M, Takavar A,
Iran J Nucl Med , Vol.18, No.1, Year. 2010, Page:7-13,
Download
70.

Synthesis and radioprotective study of novel amino-alkyldithiocarbamic acid derivatives against γ-irradiation in mice


Authors: Hosseinimehr SJ, Beiki D, Kebriaeezadeh A, Khalaj A, Pirali Hamedani M, Akhlaghpoor S, Esmaeili H, Barazesh A,
Iran J Radiat Res , Vol.7, No.2, Year. 2009, Page:91-96,
Download
71.

99mTc-MIBI whole body scintigraphy and P-glycoprotein for the prediction of multiple drug resistance for the prediction of multiple drug resistance


Authors: Fallahi B, Beiki D, Mousavi SA, Gholamrezanezhad A, Eftekhari M, Fard-Esfahani A, Alimoghadam K, Mirpour S, Skandarian A, Saghari M,
Hell J Nucl Med, Vol.12, No.3, Year. 2009, Page:255-259,
Download
72.

Giant cavernous hemangioma on Tc-99m RBC scan


Authors: Fard-Esfahani A, Chavoshi M, Eftekhari M, Fallahi B, Beiki D, Saghari M,
Iran J Nucl Med , Vol.17, No.1, Year. 2009, Page:57-60,
Download
73.

Predictors of abnormal renal cortical scintigraphy in children with first urinary tract infection: the importance of time factor


Authors: Ansari Gilani K, Modaresi Esfeh J, Gholamrezanezhad A, Gholami A, Mamishi S, Eftekhari M, Beiki D, Fard-Esfahani A, Fallahi B, Anvari A,
Int Urol Nephrol , Vol.42, No.4, Year. 2009, Page:1041-1047,
Download
74.

The role of myocardial perfusion imaging in the evaluation of patients undergoing percutaneous transluminal coronary angioplasty


Authors: Fard-Esfahani A, Assadi M, Saghari M, Mohagheghie A, Fallahi B, Eftekhari M, Beiki D, Takavar A, Nabipour I, Ebrahimi A, Izadyar S, Ansari-Gilani K,
Hell J Cardiol , Vol.50, No.5, Year. 2009, Page:396-401,
Download
75.

Assessment the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Technetium-99m phytate in breast cancer


Authors: Eftekhari M, Beiki D, Fallahi B, Arabi M, Memari F, Gholamrezanezhad A, Esmaeili J, Akhzari F, Fard-Esfahani A,
DARU Journal of Pharmaceutical Sciences, Vol.17, No.2, Year. 2009, Page:83-87,
Download
76.

High accuracy of myocardial perfusion imaging in patients with left bundle branch block: comparison of four interpretation approaches


Authors: Fallahi B, Beiki D, Eftekhari M, Ansari Gilani K, Fard-Esfahani A, Gholamrezanezhad A, Yamini Sharif A, Ansari M, Saghari M,
Hell J Nucl Med , Vol.12, No.2, Year. 2009, Page:132-137,
Download
77.

Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma


Authors: Fard-Esfahani A, Hadifar M, Fallahi B, Beiki D, Eftekhari M, Saghari M, Takavar A,
Hell J Nucl Med , Vol.12, No.1, Year. 2009, Page:37-40,
Download
78.

The radiotracer 99mTc-MIBI is not genotoxic for human peripheral blood lymphocytes


Authors: Hosseinimehr SJ, Ahmadi A, Beiki D, Mahmoudzadeh A, Babaei M, Habibi E,
Genet Mol Res , Vol.8, No.3, Year. 2009, Page:923-928,
Download
79.

Protective effects of hesperidin against genotoxicity induced by 99mTc-MIBI in human cultured lymphocyte cells


Authors: Hosseinimehr SJ, Ahmadi A, Beiki D, HabibiE, Mahmoudzadeh A,
Nucl Med Biol , No.36, Year. 2009, Page:863-867,
Download
80.

Manifestations of Ollier's disease in a 21-years old man: a case report


Authors: Fallahi B, Bostani M, Ansari Gilani K, Beiki D, Gholamrezanezhad A,
J Med Case Reports , Vol.3, Year. 2009, Page:7759,
Download
81.

Assessment of the accuracy of lacrimal scintigraphy based on a prospective analysis of patients' symptomatology


Authors: Fard-Esfahani A, Gholamrezanezhad A, Mirpour S, Tari AS, Saghari M, Beiki D, Sichani BF, Eftekhari M,
Orbit, Vol.27, No.4, Year. 2008, Page:237-241,
Download
82.

The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment


Authors: Eftekhari M, Asadollahi A, Beiki D, Izadyar S, Gholamrezanezhad A, Assadi M, Fard-Esfahani A, Fallahi B, Takavar A, Saghari M,
Hell J Nucl Med , Vol.11, No.3, Year. 2008, Page:160-163,
Download
83.

Single Tc-99m Sestamibi injection, double acquisition gated SPECT after stress and during low-dose dobutamine infusion: a new suggested protocol for evaluation of myocardial perfusion


Authors: Fallahi B, Beiki D, Gholamrezanezhad A, Mahmoudian B, Ansari Gilani K, Eftekhari M, Fard-Esfahani A, Mohseni Z, Saghari M,
Int J Cardiovasc Imaging , Vol.24, No.8, Year. 2008, Page:825-835,
Download
84.

The pattern of brain perfusion SPECT in non-medicated schizophrenic patients


Authors: Pooyafard F, Fallahi B, Assadi SM, Amini H, Beiki D, Fard-Esfahani A, Rahiminezhad F, Shahmansouri N, Mohammadi MR,
Iran J Nucl Med , Vol.16, No.1, Year. 2008, Page:43-51,
Download
85.

Comparative scintigraphic study of renal function with 99mTc-Mercaptoacetyl-triglycine and 99mTc-Ethylenedicysteine


Authors: Beiki D, Eftekhari M, Gheisari F, Hozhabrosadati M, Fard-Esfahani A, Takavar A, Gholamrezanezhad A, Saghari M, Ansari Gilani K,
DARU, Vol.16, No.1, Year. 2008, Page:41-46,
Download
86.

Quantitative assessment of dacryoscintigraphic images in the evaluation of epiphora


Authors: Gholamrezanezhad A, Fard-Esfahani A, Sadeghi-Tari A, Mirpour S, Saghari M, Eftekhari M, Fallahi B, Beiki D, Poormoslemi A, Tarbiat A,
Orbit, Vol.26, No.4, Year. 2007, Page:229-235,
Download
87.

The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma


Authors: Fard-Esfahani A, Mirshekarpour H, Fallahi B, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A,
Clin Nucl Med , Vol.32, No.9, Year. 2007, Page:696-699,
Download
88.

On-levothyroxine measurement of thyroglobulin is not a reliable test for the follow-up of patients at high risk for remnant/recurrent differentiated thyroid carcinoma


Authors: Gholamrezanezhad A, Saghari M, Mirpour S, Beiki D, Javan S, Abdollahzadeh J,
Endokrynol Pol / Polish J Endocrinol, Vol.58, No.2, Year. 2007, Page:100-104,
Download
89.

A correlative study comparing current different methods of calculating left ventricular ejection fraction


Authors: Gholamrezanezhad A, Mirpour S, Esfahani AF, Saghari M, Mirpour K, Beiki D, Soheilifar M,
Nucl Med Commun, Vol.28, No.1, Year. 2007, Page:41-48,
Download
90.

Efficacy of pilocarpine for the prevention of radiation induced xerostomia evaluated by semi-quantitative 99mTc-pertechnetate scanning in a randomized trial


Authors: Fard-Esfahani A, Haddad P, Modares Mosalla MM, Fallahi B, Eftekhari M, Saghari M, Beiki D, Takavar A,
Cancer Bulletin , Vol.1, No.2, Year. 2006, Page:65-76,
Download
91.

Catheter related artifacts on bone scanes: report of two cases


Authors: Eftekhari M, Gholamrezanezhad A, Izadyar S, Esmaili J, Mirpour S, Saghari M, Fard-Esfahani A, Fallahi Sichani B, Beiki D,
Iran J Nucl Med , Vol.14, No.1, Year. 2006, Page:21-25,
Download
92.

Brain perfusion single photon emission computed tomography findings in patients with posttraumatic anosmia and comparison with radiological imaging


Authors: Eftekhari M, Assadi M, Kazemi M, Saghari M, Mojtahedi A, Fard-Esfahani A, Sichani BF, Beiki D,
Am J Rhinol , Vol.20, No.6, Year. 2006, Page:577-81,
Download
94.

Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole-body iodine scan


Authors: Saghari M, Gholamrezanezhad A, Mirpour S, Eftekhari M, Takavar A, Fard-Esfahani A, Fallahi B, Beiki D,
Nucl Med Commun, Vol.27, No.7, Year. 2006, Page:567-72,
Download
95.

Frequency and severity of myocardial perfusion abnormalities using Tc-99m-MIBI SPECT in cardiac syndrome X


Authors: Saghari M, Assadi M, Eftekhari M, Yaghoubi M, Fard-Esfahani A, Malekzadeh J, Fallahi B, Beiki D, Takavar A,
BMC Nucl Med, Vol.6:1, Year. 2006,
Download
96.

Role of Tc-99m RBC scintigraphy in specific diagnosis of liver hemangioma


Authors: Fard-Esfahani A, Nazar-Ahari M, Assadi M, Saghari M, Eftekhari M, Fallahi B, Beiki D, Takavar A,
Alasbimn J, Vol.8, No.32, Year. 2006, Page:1-5,
Download
97.

A preliminary study of neuroSPECT evaluation of patients with posttraumatic smell impairment


Authors: Eftekhari M, Assadi M, Kazemi M, Saghari M, Fard-Esfahani A, Fallahi Sichani B, Gholamrezanezhad A, Beiki D,
BMC Nuclear Medicine , Vol.5, No.6, Year. 2005,
Download
98.

Unilateral absent lung ventilation and perfusion due to hilar mass


Authors: Gholamrezanezhad A, Eftekhari M, Fard A, Fallahi B, Beiki D,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:169-170,
Download
99.

γ-Scintigraphic evaluation of enteric-coated capsules containing chitosan-brilliant blue gel beads as hydrophilic model for colon drug delivery


Authors: Avadi MR, Ghassemi AH, Sadeghi AMM, Beiki D, Akbarzadeh A, Ebrahimnejad P, Shahhosseini S, Bayati KH, Rafiiee-Tehrani M,
J Drug Del Sci Technol, Vol.15, No.5, Year. 2005, Page:383-387,
Download
100.

The value of 99mTc-MIBI whole body scintigraphy in active and in remission multiple myeloma


Authors: Fallahi B, Saghari M, Fard A, Eftekhari M, Iravani M, Beiki D, Dabbagh VR, Sadeghi R,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:158-161,
Download
101.

Parsmedline: establishment of a web-based bibliographic database related to Iranian health and medical research


Authors: Beiki O, Beiki D,
J Med Libr Assoc , Vol.93, No.3, Year. 2005, Page:400-403,
Download
102.

Comparative evaluation of two fixed doses of 185 and 370 MBq 131I, for the treatment of Graves' disease resistant to antithyroid drugs


Authors: Fard A, Dabbagh VR, Fallahi B, Eftekhari M, Beiki D, Saghari M, Takavar A,
Hell J Nucl Med , Vol.8, No.3, Year. 2005, Page:165-168,
Download
103.

Microdose 14C Urea breath test for the diagnosis of Helicobacter Pylori: a survey in Iranian population


Authors: Dowlatabadi R, Khalaj A, Beiki D, Eftekhari M, Al-Seyed Hosein MH, Khoshayand MR,
DARU Journal of Pharmaceutical Sciences, Vol.13, No.1, Year. 2005, Page:6-10,
Download
104.

Accuracy of SPECT bone scintigraphy in diagnosis of meniscal tears


Authors: Saghari M, Moslehi M, Esmaeili J, Tahmasebi MN, Radmehr A, Eftekhari M, Fard-Esfahani A, Beiki D, Fallahi B, Gholamrezanezhad A,
Iran J Nucl Med , Vol.13, No.1, Year. 2005, Page:1-6,
Download
105.

Validation of 13C-urea breath test with non dispersive isotope selective infrared spectroscopy for the diagnosis of Helicobacter pylori infection: a survey in Iranian population


Authors: Beiki D, Khalaj A, Dowlatabadi R, Eftekhari M, Eftekhari M, Al-Seyed Hosein MH, Fard A, Fallahi B, Khoshayand MR.,
DARU Journal of Pharmaceutical Sciences, Vol.13, No.2, Year. 2005, Page:52-55,
Download
106.

Radiation dose rate and urinary activity in patients with differentiated thyroid carcinoma treated with radioiodine-131; a survey in Iranian population


Authors: Shahhosseini S, Beiki D, Dadashzadeh S, Eftekhari M, Tayebi H, Moosazadeh G,
Hell J Nucl Med, Vol.7, No.3, Year. 2004, Page:192-194,
Download
107.

Semi-quantitative assessment of salivary gland function in patients with differentiated thyroid carcinoma after radioiodine-131 treatment


Authors: Fard A, Fallahi B, Olamaei R, Eftekhari M, Beiki D, Saghari M,
Hell J Nucl Med , Vol.7, No.3, Year. 2004, Page:206-209,
Download
108.

Qualitative evaluation of Chang method of attenuation correction on heart SPECT by using custom made heart phantom


Authors: Takavar A, Eftekhari M, Beiki D, Saghari M, Mostaghim M, Sohrabi M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:13-17,
Download
109.

Effects of treatment with radioiodine (131I) on the gonadal function of the hyperthyroid patients


Authors: Eftekhari M, Takavar A, Ansari-Gilani K, Akhzari F, Fard A, Beiki D,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:7-12,
Download
110.

Comparative bioavailability of two tablet formulation of dipyridamole in healthy male volunteers


Authors: Beiki D, Amini M, Dowlatabadi R, Pirali M,
Iran J Pharm Res , Vol.2, No.4, Year. 2003, Page:213-216,
Download
111.

Synthesis of radioiodinated labeled peptides


Authors: Matloobi M, Rafii H, Beiki D, Khalaj A, Kamali-Dehghan M,
J Radioanal Nucl Chem , Vol.257, No.1, Year. 2003, Page:71-73,
Download
112.

Synthesis of 1-b-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (b-IAZA): a novel marker of tissue hypoxia


Authors: Kumar P, Ohkura K, Beiki D, Wiebe LI, Seki KI,
Chem Pharm Bull, Vol.51, No.4, Year. 2003, Page:399-403,
Download
113.

Synthesis of b-azomycin nucleosides: 1-(b-D-2-iodo-2-deoxyarabinofuranosyl)-2-nitroimidazole, a novel marker of tissue hypoxia


Authors: Kumar P, Wiebe LI, Beiki D, Ohkura K, Seki KI,
Tetrahedron Lett, Vol.43, Year. 2002, Page:4427-4429,
Download
114.

Increased selectivity in inflammatory site identification via labelling of IgG with N-succinimidyl-4-[125I]iodobenzoate


Authors: Beiki D, Shahhosseini S, Khalaj A, Eftekhari M,
J Label Compd Radiopharm , Vol.45, No.11, Year. 2002, Page:927-934,
Download
115.

A new and simple synthesis of N-succinimidyl-4-[125I]iodobenzoate involving a microwave-accelerated iodination step


Authors: Khalaj A, Beiki D, Rafiee H, Najafi R,
J Label Compd Radiopharm , Vol.44, No.3, Year. 2001, Page:235-240,
Download
116.

High performance liquid chromatographic method for determination of dipyridamole in human plasma


Authors: Beiki D, Pirali M, Amini M, Shafiee A,
DARU, Vol.7, No.2, Year. 1999, Page:14-17,
Download

Farsi

1.

Investigation of radial dose distribution and cumulative dose of radiopharmaceuticals used for pain palliation of bone metastases


Authors: Ranjbar H, Bahrami-Samani A, beiki D, Ghannadi-Maragheh M,
J Nucl Sci Technol, No.73, Year. 2015, Page:42-47,
Download
2.

Molecular imaging with PET/CT in oncology


Authors: Fard-Esfahani P, Fallahi B, Beiki D, Fard-Esfahani A, Emami-Ardekani A, Eftekhari M, Ansari M,
Iran South Med J, Vol.15, No.1, Year. 2012, Page:69-80,
Download
3.

The First Experience of Stem Cell Labeling in Iran Using 111In- Oxine


Authors: Gholamrezanezhad A, Bagheri M, Mohammadnezhad M, Mirpour S, Majd Ardekani J, Alimoghadam K, Bashtar M, Beiki D, Ansari Gilani K, Saghari M, Ghavamzadeh A, Malekzadeh R,
Iran J Nucl Med , Vol.15, No.2, Year. 2007, Page:25-27,
Download
4.

Myocardial perfusion scan accuracy in detection of coronary artery disease - Comparison with exercise stress test


Authors: Fard-Esfahani A, Fallahi B, Saghari M, Eftekhari M, Beiki D,
Iran J Nucl Med , Vol.15, No.1, Year. 2007, Page:16-23,
Download
5.

The relationship between dyspepsia and increased radiotracer uptake in the gastric wall during 99mTc-MIBI myocardial perfusion imaging


Authors: Beiki D, Gholamrezanezhad A, Mirpour S, Fallahi B, Saghari M, Eftekhari M, Fard-Esfahani A, Hajimahmoudi H,
J Mazandaran Univ Med Sci , Vol.16, No.56, Year. 2007, Page:1-8,
Download
6.

Agreement of two methods of planar and SPECT scintigraphy with 99mTc-RBC in detection of liver hemangioma


Authors: Fard-Esfahani A, Fallahi B, Khatami K, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A,
Iran J Nucl Med , Vol.14, No.2, Year. 2006, Page:8-12,
Download
7.

Myocardial 99mTc-MDP uptake on the bone scintigraphy in the hemodialysis-associated amyloidosis: A case report


Authors: Fard-Esfahani A, Assadi M, Saghari M, Eftekhari M, Fallahi Sichani B, Beiki D, Akbarpour S, Mohammadian B,
Iran J Nucl Med , Vol.13, No.2, Year. 2005, Page:1-5,
Download
8.

Evaluation of diagnostic role of 99mTc-Tetrofosmin scintigraphy in cold thyroid nodules


Authors: Eftekhari M, Saghari M, Noorani MH, Fard-Esfahani A, Beiki D, Fallahi B,
Iran J Nucl Med , Vol.13, No.2, Year. 2005, Page:25-29,
Download
9.

Radioiodine treatment effects on lacrimal glands function in patients with thyroid cancer


Authors: Fard Esfahani A, Akhzari F, Mirshekarpour H, Saghari M, Izadyar S, Esmaili J, Fallahi B, Beiki D,
Iran J Nucl Med, Vol.13, No.2, Year. 2005, Page:6-14,
Download
10.

Radiopharmaceutical regulation world wide - the resemblances and the differences


Authors: Dowlatabadi R, Beiki D, Khalaj A,
Iran J Nucl Med , Vol.13, No.1, Year. 2005, Page:1-13,
Download
11.

The value of myocardial perfusion imaging in differentiating between idiopathic dilated cardiomyopathy from the ischemic form


Authors: Fard A, Emami F, Eftekhari M, Saghari M, Fallahi B, Beiki D, Takavar A,
Iran J Nucl Med , Vol.12, No.2, Year. 2004, Page:15-20,
Download
12.

Effects of treatment with radioactive iodine on gonadal functions in patients with differentiated thyroid cancer


Authors: Fard-Esfehani A, Eftekhari M, Aliyari N, Saghari M, Beiki D,
Tehran Univ Med J -TUMJ, Vol.62, No.1, Year. 2004, Page:31-36,
Download
13.

Dystrophic calcinosis cutis and SLE; the bone scan pattern


Authors: Eftekhari M, Assadi M, Fard-Esfehani A, Beiki D, Fallahi B,
Iran J Nucl Med , Vol.12, No.2, Year. 2004, Page:1-4,
Download
14.

Reverse re-distribution in myocardial perfusion scan with 201Tl


Authors: Eftekhari M, Sadeghi R, Fard A, Beiki D, Fallahi B, Saghari M,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:25-32,
Download
15.

Value of 99mTc-MIBI scintigraphy in active disease and remission phase of multiple myeloma


Authors: Saghari M, Fallahi B, Eftekhari M, Iravani M, Izadyar S, Esmaili J, Beiki D, Fard A,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:15-23,
Download
16.

Determination of radiation dose rates and urinary activity of patients received sodium iodide-131 for treatment of differentiated thyroid carcinoma


Authors: Beiki D, Shahhosseini S, Dadashzadeh S, Eftekhari M, Tayebi H, Moosazadeh-Rashti G,
Iran J Nucl Med , Vol.12, No.1, Year. 2004, Page:1-13,
Download
17.

131I-MIBG scintigraphy in carcinoid tumor with liver metastases


Authors: Eftekhari M, Olamaei R, Fard A, Beiki D, Saghari M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:7-11,
Download
18.

Gamma-scintigraphy in the evaluation of drug delivery systems


Authors: Shahosseini S, Beiki D, Eftekhari M,
Iran J Nucl Med , Vol.11, No.2, Year. 2003, Page:21-33,
Download
19.

Radioiodine therapy effects on salivaroy gland function in patients with differentiated thyroid cancer


Authors: Fard-Esfahani A, Olamaei R, Eftekhari M, Saghari M, Beiki D,
Iran J Nucl Med , Vol.11, No.1, Year. 2003, Page:17-21,
Download

Abstracts and Presentations

Farsi

1.

18F-FDG: The Production and Quality Control


PET/CT Seminar
Location: Tehran, Iran,
13-14 April, 2017
2.

New peptide based radiopharmaceutical for melanoma imaging


20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
3.

Factors interfering with myocardial 18F-FDG uptake in oncologic PET-CT imaging


20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
4.

68Ga-Radiopharmaceuticals in PET Imaging: The future Perspectives


20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
5.

Radiopharmaceuticals Consumption: Iran vs. Global Market Review in 2014


20th Iranian Congress of Nuclear Medicine
Location: Mahmoudabad, Iran,
26-28 October, 2016
6.

Preparation and Evaluation of 68Ga-ECC as a PET Renal Imaging Agent


19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
7.

Optimized production and quality control of 68Ga-EDTMP for small clinical trials


19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
8.

Production of 68Ga-Ethyl cysteinate dimmer for PET studies


19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
9.

Nuclear Medicine Market Worldwide


19th Iranian Congress of Nuclear Medicine
Location: Hamedan, Iran,
16-18 September, 2015
10.

Turkey vs. Iran – Nuclear Medicine Comparison


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
11.

Prospective management of the production and clinical applications of radiopharmaceuticals in Iran: Opportunities and challenges


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
12.

preparation and quality control of 111In-Plerixafor for CXCR4 imaging


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
13.

synthesis and evaluation of 67Ga-plerixafor; a novel imaging agent for targeting chemokine receptor CXCR4


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
14.

Synthesis and Evaluation of [68Ga]- plerixafor for PET imaging of human colorectal carcinoma


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
15.

Radiosynthesis and biodistribution studies of [62Zn/62Cu]– plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
16.

Radiolabeling of a melanocyte stimulating hormone derivative for single photon imaging


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
17.

Production, Radiolabeling Optimization and Imaging Studies a combined 153Sm/177Lu-EDTMP formulation as a novel potential radiopharmaceutical for metastatic bone pain palliation therapy


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
18.

One step radiolabeling of peptide LIKKPF with 18FDG for detecting of apoptosis


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
19.

Comparison of curability of tumors treated with targeted radionuclide therapy and external beam radiotherapy


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
20.

Lower Limbs Perfusion Scintigraphy in Patients Referred for Myocardial Perfusion Imaging


18th Iranian Congress of Nuclear Medicine
Location: Tehran, Iran,
12-14 November, 2014
21.

Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer


14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
22.

The effectiveness of 153Sm-EDTMP for palliative therapy of patients with painful multiple bone metastases


14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
23.

The distribution of bone metastases on 146 whole body scans


14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
24.

Predicting factors of successful post-surgical remnant ablation in radioiodine-treated patients with differentiated thyroid carcinoma


14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
25.

Development of second primary cancer in radioiodine treated patients with differentiated thyroid carcinoma


14th Iranian Annual and International Congress of Nuclear Medicine
Location: Mashhad, Iran,
4-6 November, 2010
26.

PET scanning of pediatric tumors


20th international congress of pediatrics
Location: Tehran, Iran,
7-14 October, 2008
27.

New therapeutic radiopharmaceuticals in Iran


12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
28.

Preparation of patients with thyroid cancer for I-131 scintigraphy or therapy by 1-3 weeks of levothyroxine discontinuation or after total thyroidectomy


12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
29.

Pitfalls of FDG-PET imaging in oncology


12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
30.

Renal axis deviation in urinary tract abnormalities of children; the role of DMSA renal scintigraphy


12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
31.

The role of myocardial perfusion scan in diabetic patients


12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
32.

PET in gastrointestinal oncology-advantages and a few pitfalls


12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
33.

Radioiodine treatment complication in mother and child in patients with differentiated thyroid carcinoma


12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
34.

Cytotoxicity of 111In-oxine on mesenchymal stem cells: a time dependent adverse effect


12th Iranian Annual Congress of Nuclear Medicine
Location: Sari, Iran,
25-27 June, 2008
35.

Comparison between brain perfusion single photon emission computed tomography (SPECT) and anatomical imaging in chronic complications of traumatic head injury


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
36.

NeuroSPECT evaluation in patients with post-traumatic anosmia, a preliminary study


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
37.

Assessment of the accuracy of lacrimal scintigraphy based on a prospective analysis of patients’ symptomatology


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
38.

Analysis of dacryoscintigraphic images based on a simple quantitative measure


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
39.

On-levothyroxine measurement of thyroglobulin is not a reliable screening test for patients at high risk of remnant/recurrent differentiated thyroid carcinoma


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
40.

Nuclear medicine imaging techniques in the evaluation of pharmaceutical formulations


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
41.

Accuracy of myocardial perfusion scan in detection of coronary artery disease- comparison with exercise stress test


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
42.

Discontinuing of long-term beta-blocker therapy may falsely overestimate the fixed defects in dipyridamole myocardial perfusion imaging


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
43.

The best pattern of interpretation in dipyridamole myocardial perfusion scan for diagnosis of coronary artery disease in the territory of left anterior descending artery in patients with left bundle branch block


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
44.

Evaluation of a new mono-phasic imaging protocol in comparison with conventional dual-phase study of myocardial perfusion


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
45.

The relation between helicobacter pylori infection and cardiac syndrome X; a preliminary study


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
46.

The long term effects of mustard gas on myocardial perfusion pattern of intoxicated warfare patients


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
47.

The role of scintigraphicperfusion imaging in the evaluation of patients before and after percutaneous transluminal coronary angioplasty


10th Iranian Annual Congress of Nuclear Medicine
Location: Tehran, Iran,
6-7 December, 2006
48.

Indirect radionuclide cystography in children


18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
49.

Renal cortical scintigraphy in children


18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
50.

Nuclear medicine role in neonatal jaundice


18th International Congress of Pediatrics
Location: Tehran, Iran,
27 Oct-1 Nov, 2006
51.

Application of Microdose Radiolabeled 14C-Urea for the Detection of Helicobacter Pylori Infection


The 8th National Congress of Microbiology
Location: Isfahan, Iran,
23-25 May, 2006
52.

Review of the role of nuclear medicine in the management of the adrenal diseases


13th Asia-Oceania Congress of Endocrinology
Location: Tehran, Iran,
10-12 May, 2006
53.

Evaluation of congenital renal fusion anomalies with 99mTc-DMSA


17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
54.

The role of thyroid scan in evaluating of congenital hypothyroidism


17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
55.

Sedation Protocols In Pediatric Nuclear Medicine


17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
56.

Current concepts on the diagnostic and therapeutic use of MIBG in children


17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
57.

Renal dynamic scan in the pediatric urinary infections


17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
58.

PET and pediatric neurological disorders


17th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2005
59.

Production of positron emitter radiopharmaceuticals: radiolabelling techniques


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
60.

The value of myocardial perfusion imaging in differentiating between idiopathic dilated cardiomyopathy from the ischemic form


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
61.

Evaluation of diagnostic of 99mTc-Tetrofosmin scintigraphy in cold thyroid nodules


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
62.

The effectiveness of 131I therapy in thyrogloboline positive 131I whole body scan negative patients with differentiated thyroid carcinoma


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
63.

Internal dosimetry in nuclear medicine using a thyroid mathematical model


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
64.

Health and safety aspects of nuclear medicine


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
65.

Comparative study of renal function with 99mTc-MAG3 and 99mTc-EC


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
66.

Prevalence of depression in patients with differentiated thyroid cancer treated with radioactive iodine


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
67.

Quantitative assessment of salivary glands function in thyroid cancer patients after radioiodine therapy


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
68.

90Y-Ibritumomab Tiuxetan in the treatment of relapsed or refractory B-cell non-Hodgkin's Lymphoma


The 8th Annual Meeting of Nuclear Medicine
Location: Tehran, Iran,
17-18 November, 2004
69.

Radioisotopic cystography in diagnosis of vesicoureteral reflux


16th International Congress of Pediatrics
Location: Tehran, Iran,
8-13 October, 2004
70.

The value of 99mTc-MIBI Scintigraphy in active disease and remission phase of multiple myeloma


4th National Iranian Congress of Hematology & Oncology and Nursing Meeting
Location: Mashhad, Iran,
24-26 June, 2004
71.

Leukocyte radiolabelling with 99mTc-HMPAO for imaging of inflammation and infection


The First Congress of Early Detection of Disease
Location: Hamedan, Iran,
12-15 May , 2003
72.

Evaluation of new drug delivery systems using gammascintigraphy”, 1st National Conference on Novel Drug Delivery Systems


1st National Conference on Novel Drug Delivery Systems
Location: Tehran, Iran,
26-27 February, 2003
73.

Synthesis of b-2-IAZA, a novel radiotracer of tissue hypoxia


The 6th Iranian Annual Meeting of Nuclear Medicine
Location: Mashhad, Iran,
19-21 October, 2002
74.

A novel synthesis of 125I-labelled N-succinimidyl-4-idobenzoate for use in antibody labelling


8th Iranian Seminar of Pharmaceutical Sciences
Location: Shiraz, Iran,
27-29 August, 2002
75.

Synthesis of radioiodinated of N-succinimidyl-4-idobenzoate for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine


7th Iranian Organic Chemistry Conferences
Location: Tehran, Iran,
12-13 September, 1999
76.

A HPLC method for evaluation of bioavailability of generic dipyridamole tablets


Second Iranian Seminar of Pharmacy Students
Location: Mashhad, Iran,
21-22 October, 1995

English

1.

Diagnostic nuclear medicine procedures and resulting radiation dose of Tehran population in 2011-2014


29th Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
15-19 October, 2016
2.

Factors Influencing the Pattern and Intensity of Myocardial FDG Uptake in Oncologic PET-CT Imaging


29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
3.

Comparison of sensitivity and specificity of Tc-99m octreotide and I-131 MIBG scintigraphies in diagnosis and localization of pheochromocytoma and neuroblastoma


29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
4.

Association between FDG-PET/CT Findings and Tumor Markers in Patients with Colorectal Carcinoma


29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
5.

Preparation and biological evaluation of 99mTc-HYNIC-LIKKPF for the detection of apoptosis


29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
6.

18F-FDG-Aoe-LIKKP-Pyr-A: A new peptide radiotracer for apoptosis imaging


29th Annual Congress of the European Association of Nuclear Medicine
15-19 October, 2016
7.

Early and late follow-up myocardial perfusion scan in patients with breast cancer after external radiotherapy


29th Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
15-19 October, 2016
8.

Efficacy and complications of 153Sm-EDTMP added to palliative local radiotherapy for bone metastases


World Congress of Brachytherapy
Location: San Francisco, USA,
27-29 June, 2016
9.

Preliminary report of long term follow-up with myocardial perfusion scan in breast cancer patients after external beam radiation therapy


28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
10.

Evaluation of 99mTc-TRODAT-1 SPECT in the diagnosis of Parkinson’s disease and its differentiation from the other types of parkinsonism syndroms - A pilot study


28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
11.

Effect of I-131 MIBG Thyroid Uptake on Thyroid Function Tests


28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
12.

A new lactam bridge 99mTc-α -melanocyte-stimulating hormone analog for diagnosis of metastatic melanoma


28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
13.

Synthesis and radiolabeling of HYNIC-conjugated LIKKPF peptide with 18F-FDG for the detection of apoptosis


28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
14.

Assessment of prognosis in differentiated thyroid carcinoma patients showing detectable thyroglobulin level 6 months after therapy based on radioactive iodine whole body scan results (A preliminary report)


28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
15.

Radioioeine retreatment or wait for a limited time in patients with differentiated thyroid carcinoma with negative thyroglobulin and antithyroglobulin, but remained thyroid residue after post-surgery radioiodine ablative therapy


28th Annual Congress of the European Association of Nuclear Medicine
Location: Hamburg, Germany,
10-14 October, 2015
16.

Preparation and evaluation of 68Ga-ECC as a PET renal imaging agent


45th Annual Scientific Meeting of the Australian and New Zealand Society of Nuclear Medicine (ANZSNM)
Location: Brisbane, Australia,
17-20 April, 2015
17.

Preparation and preliminary biological evaluation of [153Sm] samarium AMD3100; towards a possible therapeutic chemokine receptor CXCR4 targeting complex


27th Annual Congress of the European Association of Nuclear Medicine
Location: Gothenburg, Sweden,
18-22 October, 2014
18.

Relationship between myocardial perfusion indices and mechanical dyssynchrony based on gated SPECT phase analyses in patients with coronary artery disease and heart failure


11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
19.

Radionuclide bone pain palliation, experience in Iran


11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
20.

Radiosynthesis and biodistribution studies of [62Zn/62Cu]-Plerixafor complex as a novel in vivo PET generator for chemokine receptor imaging


11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
21.

Synthesis and preliminary evaluation of a new 99mTc labeled substance P analogue as a potential tumor imaging agent


11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
22.

Evaluation of a new 99mTc-Bombesin analog in differentiation of malignant from benign breast tumors


11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
23.

Evaluation of 188Re-HEDP efficacy in metastatic bone pain palliation therapy


11th Congress of World Federation of Nuclear Medicine & Biology
Location: Cancun, Mexico,
27-31 September, 2014
24.

Quality of life and associated factors in radio-iodine treated patients with differentiated thyroid carcinoma


26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
25.

Comparison of Salivary Gland Function Side Effect of 30-100 mCi versus <30 mCi of Radioiodine Therapy


26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
26.

Preliminary report of randomized clinical trial for assessment of the short term Folate therapy on transient ischemic dilatation in myocardial perfusion scan of diabetic patients


26th Annual Congress of the European Association of Nuclear Medicine
Location: Lyon, France,
19-23 October, 2013
27.

Evaluation of Myocardial Perfusion and Function after Kidney Transplantation by Gated Myocardial Perfusion Scintigraphy


25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
28.

The Influence of resolution recovery during image reconstruction on quantitative brain SPECT imaging


25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
29.

Comparative evaluation of the diagnostic accuracy of Tc-99m-sestamibi gated SPECT using five different sets of image acquisitions at stress and rest phases for the diagnosis of coronary artery disease


25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
30.

Evaluation of 99mTc-Bombesin in differentiation of malignant from benign breast tumors


25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
31.

The value of quantitative myocardial perfusion scintigraphy using 99mTc-MIBI ECG-Gated SPECT for determining the clinical prognosis in patients suspicious for coronary artery disease


25th Annual Congress of the European Association of Nuclear Medicine
Location: Milan, Italy,
27-31 October, 2012
32.

Evaluation of 99mTc-Ubiquicidin 29-41 Scintigraphy in Differentiation of Bacterial Infection from Sterile Inflammation in Diabetic Foot


24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
33.

Evaluation of treatment efficacy of metastatic bone pain with 153Sm-EDTMP


24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
34.

Evaluation of 99mTc-Ubiquicidin scintigrapghy in differentiation of bacterial infection from sterile inflammation in suspected orthopedic implants


24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
35.

of estimates of renal function by Modification of Diet for Renal Disease equation in Iranian patients with acute renal failure


24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
36.

Nasolacrimal Duct Obstruction as a Complication of Iodine-131 Therapy in Patients with Thyroid Cancer


24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
37.

The role of tecnetium-99m ECD SPECT in the evaluation of long-term outcome after mild traumatic brain injury


24th Annual Congress of the European Association of Nuclear Medicine
Location: Birmingham, UK,
15-19 October, 2011
38.

Predicting factors of successful postsurgical remnant ablation with I-131 in patients with differentiated thyroid carcinoma


23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
39.

The effect of radioiodine treatment on the development of second primary cancer in patients with differentiated thyroid carcinoma


23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
40.

Scintigraphic pattern of bone metastases in 146 patients with different types of cancers


23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
41.

The precision of Cockcroft-Gault formula for estimation of glomrular filtration rate in acute renal failure in comparison with double plasma sample method using Tc-99m DTPA


23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
42.

Is gall bladder ejection fraction using fatty meal CCK cholescintigraphy useful for diagnosis of chronic cholecystitis


23rd Annual Congress of the European Association of Nuclear Medicine
Location: Vienna, Austria,
9-13 October, 2010
43.

Diffusion ofnuclear medicine in developing countries: the obstacles and barriers


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
44.

Is gall bladder ejection fraction using fatty meal CCK cholescintigraphy useful for diagnosis of chronic cholecystitis


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
45.

Radiation synovectomy, effectiveness of P-32 in treatment of chronic haemophilic synovitis


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
46.

Controversies in treatment of differentiated thyroid carcinoma, concerns regarding response vs adverse effects of I-131


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
47.

Echocardiographic left ventricular functional changes in subclinical hyperthyroidism and acute hypothyroidism in patients with thyroid cancer


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
48.

In vitro tracking of 111In-Oxine labeled mesenchymal stem cells following intravenous infusion in patients with advanced cirrhosis


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
49.

The value of transient ischemic dilatation in the presence of normal myocardial perfusion


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
50.

The brain perfusion pattern in non-medicated schizopherenic patients


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
51.

P-Glycoprotein assay and 99mTc-MIBI imaging in relation to multiple drug resistance in patients with multiple myeloma


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
52.

SPECT vs. planar scintigraphy with 99mTc-RBC for diagnosis of liover hemangioma


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
53.

Planning a new policy based on dose rates and radioiodine urinary excretion measurements for determining a proper time of discharge in radioiodine treated patients with differentiated thyroid carcinoma


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
54.

Evaluation of radioprotective effects of new synthetic amino-alkyldithiocarbamic acid derivatives in mice


10th Congress of World Federation of Nuclear Medicine & Biology
Location: Cape Town, South Africa,
18-23 September, 2010
55.

99mTc-MIBI redistribution in myocardial perfusion SPECT of the patients with coronary artery disease


22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
56.

Does vitamin-E Decrease Salivary Gland Damage After Radioiodine Therapy in Patients with Thyroid Cancer


22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
57.

Radioprotective effects of hesperidin as a flavonoid against genotoxic effects of 99mTc-MIBI in human cultured lymphocytes


22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
58.

Echocardiographic functional changes in subclinical hyperthyroidism and acute hypothyroidism after L-thyroxine withdrawal in patients with thyroid cancer


22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
59.

Genotoxicity effects of 99mTechnetium-MIBI in human peripheral blood lymphocytes


22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
60.

The Changes of the Brain Perfusion Pattern in Schizophrenic Patients in Relation to Symptom Improvement after Treatment with Olanzapine


22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
61.

Gated myocardial perfusion SPECT: Effect of patient position on left ventricular functional indices


22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
62.

Value of single injection-double acquisition stress gated SPECT before and during low-dose dobutamine infusion for prediction of myocardial perfusion and function improvement after coronary artery bypass graft


22nd Annual Congress of the European Association of Nuclear Medicine
Location: Barcelona, Spain,
10-14 October, 2009
63.

value of myocardial perfusion imaging for prediction of perfusion improvement after percutaneous transluminal coronary angioplasty


SNM Annual Meeting
Location: Toronto, Canada,
13-17 June, 2009
64.

Effects of 111In-Oxine labeling on the survival of human mesenchymal stem cells


9th Acia-oceania Congress of Nuclear Medicine and Biology
Location: New Dehli, India,
24-29 October, 2008
65.

Iodine-131 Therapy Complications In Mother And Child In Patients With Differentiated Thyroid Carcinoma


21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
66.

Radio-iodine therapy and Helicobacter pylori infection: The first in vivo evidence on radiosensitivity of the bacteria


21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
67.

Synthesis and radioprotective effects of novel amino-alkyldithiocarbamic acid derivatives against γ-irradiation in mice


21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
68.

Deviated renal axis in children with urinary tract abnormalities


21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
69.

Diagnostic value of transient left ventricular dilatation for diabetic and non-diabetic patients with no significant regional myocardial perfusion abnormality


21th Annual Congress of the European Association of Nuclear Medicine
Location: Munich, Germany,
11-15 October, 2008
70.

Evaluation of radioiodine therapy in differentiated thyroid cancer (DTC) in patients with negative diagnostic I-131 whole body scans and elevated serum thyroglobulin levels: a comparison study with thallium scan


20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
71.

Hospital discharge policy in patients receiving iodine-131 therapy for thyroid carcinoma based on monitoring of radiation dose rate and radioiodine urinary excretion


20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
72.

Simple synthesis of radioiodinated N-succinimidyl-4iodobenzoate: an intermediate compound for the indirect radioiodination of antibodies


20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
73.

Brain perfusion abnormalities in patients with chronic symptoms studied with Technetium-99m ethyl cysteinate dimmer (99mTc-ECD) more than one year


20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
74.

The value of 99mTc-MIBI scintigraphy for the diagnosis of multiple drug resistance in multiple myeloma patients


20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
75.

Angiographic findings in cardiac syndrome X comparing with myocardial perfusion imaging and exercise treadmill test


20th Annual Congress of the European Association of Nuclear Medicine
Location: Copenhagen, Denmark,
13-17 October, 2007
76.

Radioiodine treatment complications in mother and child in patients with differentiated thyroid carcinoma


Joint Annual Scientific Meeting
Location: Toronto, Canada,
9-13 October, 2007
77.

Efficacy of Radioiodine therapy in patients of differentiated thyroid cancer with elevated serum thyroglobulin and negative I-131 scan


2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
78.

Mineral Density in patients with well-differentiated thyroid carcinoma


2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
79.

Radioiodine therapy effects on lacrimal gland function in patients with thyroid cancer


2nd Conference of Asia Regional Cooperative Council of Nuclear Medicine
Location: Ulaanbaatar, Mongolia,
3-7 September, 2007
80.

Assessing the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using Tc-99m Phytate in breast cancer


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
81.

Diagnostic role of Tc-99m Tetrofosmin scintigraphy in cold thyroid nodules


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
82.

Changes in gonadal function in hyperthyroid patients treated with radioiodine


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
83.

C-13 UBT by non dispersive isotope selected infrared (NDIR) spectroscopy vs C-14 UBT in diagnosis of HP infection


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
84.

Microdose C-14 urea breath test for the diagnosis of helicobacter pylori


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
85.

Discontinuing of long-term beta-blocker therapy may falsely overestimate the fixed defects in dipyridamole myocardial perfusion imaging


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
86.

Comparison between three interpretative methods for diagnosis of coronary artery disease in the territory of left anterior descending artery by dipyridamole myocardial perfusion imaging in patients with left bundle branch block


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
87.

Myocardial perfusion scan accuracy in detection of coronary artery disease – comparison with exercise stress test


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
88.

Quantitative assessment of dacrioscintigraphic images in the evaluation of epiphora


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
89.

Radiopharmaceutical regulation world wide- the resemblances and differences


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
90.

Assessment of the Accuracy of lacrimal scintigraphy based on a prospective analysis of patients symptomatology


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
91.

Neurospect evaluation in patients with post traumatic anosmia; a preliminary study


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
92.

Comparison between brain perfusion single photon emission computed tomography and anatomical imaging in chronic complications of traumatic head injury


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
93.

Efficacy of radioiodine therapy in the treatment of elevated serum thyroglobuline in patients with differentiated thyroid carcinoma and negative whole body iodine scan


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
94.

Angiographic and scintigraphic features of cardiac X syndrome


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
95.

Myocardial perfusion scintigraphy role in evaluating percutaneous transluminal coronary angioplasty (PTCA) in patients with coronary artery disease


9th Congress of World Federation of Nuclear Medicine & Biology
Location: Seoul, South Korea,
22-27 October, 2006
96.

Discontinuing of long-term beta-blocker therapy may falsely overestimate the fixed defects in dipyridamole myocardial perfusion imaging


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
97.

Pre-treatment preparation of patients with differentiated thyroid carcinoma within three weeks


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
98.

99mTc-EC vs. 99mTc-MAG3: A comparative study of two radiopharmaceuticals for renal function assessment


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
99.

Radioiodine treatment effects on lacrimal gland function in patients with thyroid cancer


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
100.

Correlation of two methods of planar and SPECT scintigraphy with Tc-99m RBC in detection of liver hemangioma


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
101.

99mTc-Phytate vs. 99mTc-Sb2S3 for lymphatic mapping and gamma-guided sentinel lymph node biopsy in breast cancer: a comparative study


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
102.

Assessing the diagnostic accuracy of sentinel lymph nodes lymphoscintigraphy using 99mTc-phytate in breast cancer


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
103.

Comparison of methods for determination of glomerular filtration rate: low and high dose Tc-99m-DTPA renography, predicted creatinine clearance method and plasma sample method


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
104.

Is there any correlation between the severity of anxiety and myocardial perfusion abnormalities detected by SPECT imaging


19th Annual Congress of the European Association of Nuclear Medicine
Location: Athens, Greece,
30 Sept-4 Oct, 2006
105.

On-levothyroxine measurement of thyroglobulin is not a reliable screening test for patients at high risk of remnant/recurrent differentiated thyroid carcinoma


8th European Congress of Endocrinology
Location: Glasgow, UK,
1-5 April, 2006
106.

Efficacy of high dose radioiodine in the treatment of elevated serum thyroglobulin in patients with differentiated thyroid carcinoma and negative whole body iodine scan


8th European Congress of Endocrinology
Location: Glasgow, UK ,
1-5 April, 2006
107.

Bone SPECT value for differentiating malignant from benign lesions of vertebral column in patients with known primary malignancy


Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
108.

The value of Tc-99m-MIBI scintigraphy in multiple myeloma for early detection of relapsed disease and decesion for treatment


Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
109.

The value of myocardial perfusion imaging in differentiating between idiopathic dilated cardiomyopathy from the ischemic form


Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
110.

Posttraumatic anosmia: quantitative brain perfusion SPECT and clinical evaluation


Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
111.

Can rest phase study be replaced by acquisition during low-dose dobutamine infusion in ECG-gated myocardial perfusion SPECT? A novel protocol


Annual Congress of the European Association of Nuclear Medicine
Location: Istanbul, Turkey,
15-19 October, 2005
112.

Study of ablation efficiency of 3600 MBq of I-131 in the treatment of thyroid carcinoma


International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
113.

The rate of depression and its risk stratification in patients with differentiated thyroid cancers treated with radioactive iodine


International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
114.

Comparative evaluation of the two fixed dose methods of radioiodine therapy (185 MBq and 370 MBq) for the treatment of graves' disease


International Conference on Radiopharmaceutical Therapy
Location: Limassol, Cyprus,
11-14 October, 2005
115.

Bone mineral density in patients with differentiated thyroid cancer receiving suppressive dose of levothyroxine


52nd Annual Meeting of the Society of Nuclear Medicine
Location: Toronto, Canada,
18-22 June, 2005
116.

Effects of treatment with radioiodine (I-131) on the gonadal function of the hyperthyroid patients


51st Annual Meeting of the Society of Nuclear Medicine
Location: Philadelphia, PA, USA,
19-23 June, 2004
117.

Reduction of in vivo deiodination of radioiodinated of antibodies using N-succinimidyl-4-[125I]iodobenzoate


8th Congress of The World Federation of Nuclear Medicine and Biology
Location: Santiago, Chile,
29 Sept - 4 Oct , 2002
118.

Synthesis of I-125, I-131 labelled peptides


4th International Conference on isotopes
Location: Capetown, South Africa,
10-14 March, 2002
119.

Optimization of synthesis and quality control procedures for the preparation of I-125-labelled peptides


International Atomic Energy Agency, Final Research Co-ordinated Meeting
Location: Shanghai, China,
30 October - 3 November, 2000
120.

Microwave-accelerated radiohalogenation of nitroimidazole-based hypoxia markers


Fourth International Symposium on Radiohalogens
Location: Whistler, Canada,
9-13 September, 2000
121.

Synthesis and radiohalogenation of 2’-IAZA, a potential analog of IAZA, as a novel radiotracer for imaging tissue hypoxia


AFPC Conferences
Location: Saskatoon, Canada,
24-26 June, 2000
1.

Pharmaceutical and Biomedical Research


Editorial Board Member,
2.

Iranian Journal of Nuclear Medicine


Editor,
3.

Asia Oceania Journal of Nuclear Medicine and Biology


Editorial Board Member,
4.

Open Cardiovascular Imaging Journal


Editorial Board Member,
5.

Iranian Journal of Basic Medical Sciences


Referee,
6.

The Journal of Nuclear Medicine Technology


Referee,
7.

Iranian Journal of Pharmaceutical Research


Referee,
8.

Tehran University Medical Journal


Referee,
9.

Daru


Editorial Board Member,
10.

Journal of Nuclear Sciences and Technology


Editorial Board Member,
11.

Mazandaran University of Medical Sciences Journal


Referee,
12.

Applied Radiation and Isotopes


Referee,
1.

Computer Knowledge


Microsoft Word - Powerpoint - SPSS - EndNote - Reference Manager

1.

European Association of Nuclear Medicine


Activity Type:Member
2.

National Center of Excellence in Nuclear Medicine


Activity Type:Member Of Board
3.

National Center of Excellence in Radiopharmaceuticals


Activity Type:Member Of Board
4.

Cancer Research Network


Activity Type:Member
5.

Nuclear Medicine National Board of Examination


Activity Type:Member Of Board
6.

Radiopharmacy National Board of Examination


Activity Type:Member Of Board
7.

European Association of Nuclear Medicine


Activity Type:Member
8.

Iranian Society of Nuclear Medicine


Activity Type:Member
9.

Iranian Association of Pharmacists


Activity Type:Member
10.

Iranian Medical Council


Activity Type:Member
1. Therapeutic Radiopharmaceuticals
2. Hospital radiopharmacy
3. Gammascintigraphy in the evaluation of pharmaceuticals dosage forms
4. Quality control in radiopharmacy
5. Synthesis of radiosensitizers and radioprotectors
Top